prikaz prve stranice dokumenta Nuspojave sistemskog liječenja karcinoma
  Download
PDF 632.85 KB
Scientific paper - Review paper
Nuspojave sistemskog liječenja karcinoma
Medicina Fluminensis : Medicina Fluminensis, 51 (2015), 3; 332-339. urn:nbn:hr:184:008634
Radić, Mladen; Belac-Lovasić, Ingrid; Redžović, Arnela; Pavlović, Sanja; Dobrila-Dintinjana, Renata

Institutional repository: Repository of the University of Rijeka, Faculty of Medicine

Cite this document

Radić, M., Belac Lovasić, I., Redžović, A., Pavlović, S. & Dobrila Dintinjana, R. (2015). Nuspojave sistemskog liječenja karcinoma. Medicina Fluminensis : Medicina Fluminensis, 51. (3), 332-339. Retrieved from https://urn.nsk.hr/urn:nbn:hr:184:008634

Radić, Mladen, et al. "Nuspojave sistemskog liječenja karcinoma." Medicina Fluminensis : Medicina Fluminensis, vol. 51, no. 3, 2015, pp. 332-339. https://urn.nsk.hr/urn:nbn:hr:184:008634

Radić, Mladen, Ingrid Belac Lovasić, Arnela Redžović, Sanja Pavlović and Renata Dobrila Dintinjana. "Nuspojave sistemskog liječenja karcinoma." Medicina Fluminensis : Medicina Fluminensis 51, no. 3 (2015): 332-339. https://urn.nsk.hr/urn:nbn:hr:184:008634

Radić, M., et al. (2015) 'Nuspojave sistemskog liječenja karcinoma', Medicina Fluminensis : Medicina Fluminensis, 51(3), pp. 332-339. Available at: https://urn.nsk.hr/urn:nbn:hr:184:008634 (Accessed 27 April 2024)

Radić M, Belac Lovasić I, Redžović A, Pavlović S, Dobrila Dintinjana R. Nuspojave sistemskog liječenja karcinoma. Medicina Fluminensis : Medicina Fluminensis [Internet]. 2015 September 01 [cited 2024 April 27];51(3):332-339. Available at: https://urn.nsk.hr/urn:nbn:hr:184:008634

M. Radić, I. Belac Lovasić, A. Redžović, S. Pavlović and R. Dobrila Dintinjana, "Nuspojave sistemskog liječenja karcinoma", Medicina Fluminensis : Medicina Fluminensis, vol. 51, no. 3, pp. 332-339, September 2015. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:184:008634. [Accessed: 27 April 2024]

Metadata
Title (croatian)Nuspojave sistemskog liječenja karcinoma
Title (english)Side-effects of systemic antitumor therapy
AuthorMladen Radić
AuthorIngrid Belac-Lovasić
AuthorArnela Redžović
AuthorSanja Pavlović
AuthorRenata Dobrila-Dintinjana
Author's institutionUniversity of Rijeka
Faculty of Medicine
(Department of Oncology and Radiotherapy)
Scientific / art field,
discipline and subdiscipline		BIOMEDICINE AND HEALTHCARE
Clinical Medical Sciences
Oncology
Abstract (croatian)
Sistemska antitumorska terapija (kemoterapija, imunoterapija, hormonalna terapija) oblik je liječenja koji se sastoji od neprekidne upotrebe lijekova što uništavaju ili kontroliraju rast zloćudnih stanica. Može se davati kao jedan lijek ili kao kombinacija lijekova. Mnogi od citostatika koji se koriste mogu prouzrokovati popratne pojave. Te pojave jako se razlikuju kod pojedinih pacijenata. Kemoterapija djeluje na stanice koje se brzo dijele. To mogu biti normalne stanice, kao i stanice tumora. Posljednjih godina liječimo oboljele ciljanom terapijom (engl. targeted therapy) koja selektivno djeluje na stanice raka, a minimalno na normalne stanice, iako ima neke druge vrste nuspojava.
Abstract (english)
Systemic antitumor therapy (chemotherapy, hormon therapy and immunotherapy) is a form of treatment which consists of continuous use of drugs that destroy or control growth of malignant cells. It can be administered as a single drug or combination of drugs. The drugs used in chemotherapy protocols often cause side effects which are very variable depending of individual patient. Systemic antitumor therapy strong effects on cells that divide rapidly and destroy tumor cells as normal cells. In recent years, we treat our patients with targeted therapies which selectively act on cancer cells, and minimally harm normal cells, although they have some other types of side effects.
Keywords (croatian)
Keywords (english)
Languagecroatian
Publication typeScientific paper - Review paper
Publication statusPublished
Peer reviewPeer review
Publication versionPublished version
Journal titleMedicina Fluminensis : Medicina Fluminensis
Numberingvol. 51, no. 3, pp. 332-339
p-ISSN0025-7729
URN:NBNurn:nbn:hr:184:008634
Publication2015-09-01
Document URLhttp://hrcak.srce.hr/144018
Type of resourceText
Access conditionsOpen access
Terms of useLicence In copyright icon
Created on2017-04-25 08:58:47